Shares of BioLife Solutions BLFS moved higher by 4.2% in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were up 100.00% over the past year to ($0.00), which beat the estimate of ($0.07).
Revenue of $31,204,000 up by 214.56% year over year, which beat the estimate of $27,550,000.
Looking Ahead
BioLife Solutions hasn't issued any earnings guidance for the time being.
The upcoming fiscal year's revenue expected to be between $108,000,000 and $117,000,000.
Conference Call Details
Date: Aug 12, 2021
Time: 04:30 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/w4ueyrtd
Technicals
52-week high: $50.45
Company's 52-week low was at $18.20
Price action over last quarter: Up 61.60%
Company Overview
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
